Conjupro Biotherapeutics, Inc.

This early-phase study tests CPO301, a drug that delivers chemotherapy directly to cancer cells, in adults with advanced solid tumors (e.g., lung, breast, colorectal) that have stopped responding to standard treatments. The main goals are to find a safe dose and check for early s…

This early-phase trial tests an investigational drug called SYS6043 in adults with advanced or metastatic solid tumors that have spread or no longer respond to standard treatments. The main goals are to find a safe dose, understand side effects, and see if the drug can slow tumor…

This is the first study in people to test a new drug called JMT108 for advanced solid tumors that have not responded to standard treatments. The main goals are to find a safe dose, see how the body processes the drug, and look for early signs that it can shrink tumors. About 270 …